Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of multiple doses of IBI3002 in patients with asthma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IBI3002

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Asthma | Phase 1 | Status: RECRUITING